1Brenner RM, Nayak NR, Slayden OD, et al. Premenstrual and menstrual changes in the macaque and human endometrium :relevance to endometriosis. Ann N Y Acad Sci, 2002, 955: 60-74.
2Smith SK. Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab, 2001,12:147-151.
3Critchley HO, Jones RL, Lea RG, et al. Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Matab,1999,84:240-248.
4Salamonsen LA, Woolley DE. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol,1999,44:1-27.
5Osteen KG, Bruner-Tran KL, Keller NR, et al. Progesterone-mediated endometrial maturation limits matrix metalloproteinase(MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis. Ann N Y Acad Sci,2002,955:37-47.
6Osteen KG, Bruner-Tran KL, Ong D, et al. Paracrine mediators of endometrial metrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis. Ann N Y Acad Sci,2002,955:139-146.
7Osteen KG, Keller NR, Feltus FA, et al. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol Obstet Invest,1999,48 Suppl:2-13.
8Osteen KG, Bruner-Tran KL, Ong DE, et al. Progesterone or retinoic acid treatment of human endometrial tissue reduces basal and cytokine-stimulated MMP expression and increases TIMP-1 secretion. Biol Reprod, 2000,62:230.
9Bruner-Tran KL, Eisenberg E, Yeaman GR, et al. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab,2002,87:4782-4791.
10Kapiteijn K, Koolwijk P,Van Der Weiden RV, et al. Steroids and cytokines in endometrial angiogenesis. Anticancer Res,2001,21:4231- 4242.
